Targeting interleukin-1: implications for long-term cardiovascular management following radiotherapy
Eur Heart J
.
2019 Aug 7;40(30):2504-2506.
doi: 10.1093/eurheartj/ehz313.
Authors
Christos P Kotanidis
1
,
Charalambos Antoniades
1
Affiliation
1
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Level 6 West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK.
PMID:
31114848
DOI:
10.1093/eurheartj/ehz313
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Arteritis*
Cardiovascular Diseases*
Cardiovascular System*
Humans
Interleukin-1
Radiation Injuries*
Substances
Interleukin-1
Grants and funding
FS/16/15/32047/BHF_/British Heart Foundation/United Kingdom
TG/16/3/32687/BHF_/British Heart Foundation/United Kingdom